No Angel. IMO Hema trials will be carried out at Cambridge, the holy grail of research. Connections to the dream team and Pfiz%%. Licencing to sell Hema,Dcellvax, Hema II etc etc etc etc. could occur in Europle/Asia. think of the potential in a market that could be 10X of the north America market. Brace for da wallop!
David James Graham White, M.D., Ph.D.
Dr. White is a member of the Surgery and Immunology faculty of The Schulic School of Medicine, University of Western Ontario. He is one of the leading experts on using regenerative medicine transplant procedures to treat pancreatic conditions, including diabetes. He is also the Chief Scientific Officer of Sernova Corp and was formerly a Therapeutic Area Head for Novartis. He received the B.Sc. degree from the University of Surrey and the M.D. and Ph.D. degrees from Cambridge University.